Advanced Medical Solutions Group Plc · LSE:AMS
Advanced Medical Solutions — Shareholder Meeting (June 2018)
8 slides from Advanced Medical Solutions's shareholder meeting presentation, Jun 6, 2018
Slide 1: AGM Presentation June 6th 2018
Advanced Medical Solutions Group plc AGM Presentation June 6th 2018 Christopher Meredith Chief Executive Officer
Slide 2: 2017 Business Highlights
Advanced Medical Solutions Group plc 1 2017 Business Highlights • Group revenues up 16% to £96.9m and by 12% at constant currency • Branded and OEM both performing well: - Branded revenues up 22% to £55.2m (2016: £45.4m) and by 16% at constant currency - OEM revenues up 10% to £41.7m (2016: £37.8m)
Slide 3: Multiple product growth drivers
Advanced Medical Solutions Group plc 2 Multiple product growth drivers Surgical ActivHeal Dressings Sutures Collagens Multiple LiquiBand Fix8 Internal growth sealants drivers Foams Antimicrobials LiquiBand
Slide 4: Our Business Units
Advanced Medical Solutions Group plc 3 Our Business Units Branded OEM • Selling, marketing and innovation of all • Distribution, marketing and innovation of AMS branded products products that are supplied to medical • Sold directly and through distributors device partners under their own brands • 20
Slide 5: Branded: 2017 Progress
Advanced Medical Solutions Group plc 4 Branded: 2017 Progress Revenue up 16% to £55.2 million (2016: £45.4 million) • LiquiBand® LiquiBand® Revenue Revenue up 30% to £26.0m (2016: £19.3m) 30 • US sales up 40% to £18.2m (2016: £12.4m) 25 • US market share up to 26% (2016: 23%) • UK and Germany up 10%
Slide 6: Branded: 2017 Progress (continued)
Advanced Medical Solutions Group plc 5 Branded: 2017 Progress (continued) RESORBA® Revenue • RESORBA® 25 20 Revenue up 6% to £20.8m (2016: £18.1m) 15 • Sutures up 6% to £13m (2016: £11.3m) 10 • Bio-surgical products up 8% to £7.9m (2016: £6.8m) 5 0 FY 2015 FY 2016 FY 2017 £m • ActivHeal® Revenue up
Slide 7: OEM: 2017 Progress
Advanced Medical Solutions Group plc 6 OEM: 2017 Progress Revenue up 8% at £41.7m (2016: £37.8m) • Antimicrobial dressings up 9% to £19.4m (2016: £17.5m) - Silver alginate products up 9% to £18m (2016: £16.2m) • Non-antimicrobial foams down 20% to £7.4m (2016: £8.8m) impacted by pipeline fill in 201
Slide 8: Outlook
Advanced Medical Solutions Group plc 7 Outlook • Well positioned to deliver continued growth • Highly cash generative, good profitability with resources to execute M&A strategy • Board remains optimistic about long-term prospects
Advanced Medical Solutions Group — Shareholder Meeting (June 2018) on 6ix